Difficulty: Medium
Average Score: 68%
Practice
This drug both inhibits an enzyme and indirectly enhances clearance of low density lipoproteins (LDL):
Correct answer
B
Rationale
The correct answer is B) Lovastatin (Mevacor) because it is a statin drug that inhibits the enzyme HMG-CoA reductase, which plays a key role in cholesterol synthesis. By inhibiting this enzyme, lovastatin reduces the production of cholesterol in the liver, leading to a decrease in LDL levels. Additionally, lovastatin indirectly enhances the clearance of LDL from the bloodstream.
Option A) Cholestyramine (Questran) is a bile acid sequestrant that works in the intestines by binding to bile acids, leading to increased excretion of bile acids and cholesterol. However, it does not directly inhibit an enzyme involved in cholesterol synthesis.
Option C) Nicotinic acid (Niacin) is a B vitamin that can help increase HDL ("good") cholesterol levels and decrease LDL cholesterol levels, but it does not directly inhibit an enzyme involved in cholesterol synthesis.
Option D) Probucol (Lorelco) is a lipid-lowering agent that works by increasing the clearance of cholesterol from the blood, but it does not inhibit an enzyme involved in cholesterol synthesis.
Understanding the mechanisms of action of different drugs used in managing cholesterol levels is crucial for healthcare professionals in making informed decisions about treatment options for patients with dyslipidemia. This knowledge helps in selecting the most appropriate drug based on the patient's lipid profile, comorbidities, and potential drug interactions, ultimately improving patient outcomes.
Option A) Cholestyramine (Questran) is a bile acid sequestrant that works in the intestines by binding to bile acids, leading to increased excretion of bile acids and cholesterol. However, it does not directly inhibit an enzyme involved in cholesterol synthesis.
Option C) Nicotinic acid (Niacin) is a B vitamin that can help increase HDL ("good") cholesterol levels and decrease LDL cholesterol levels, but it does not directly inhibit an enzyme involved in cholesterol synthesis.
Option D) Probucol (Lorelco) is a lipid-lowering agent that works by increasing the clearance of cholesterol from the blood, but it does not inhibit an enzyme involved in cholesterol synthesis.
Understanding the mechanisms of action of different drugs used in managing cholesterol levels is crucial for healthcare professionals in making informed decisions about treatment options for patients with dyslipidemia. This knowledge helps in selecting the most appropriate drug based on the patient's lipid profile, comorbidities, and potential drug interactions, ultimately improving patient outcomes.